AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Overview of attention for article published in Lancet Neurology, April 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 5 news outlets
blogs: 5 blogs
policy: 2 policy sources
twitter: 8 X users
patent: 11 patents

facebook: 3 Facebook pages
wikipedia: 23 Wikipedia pages
reddit: 1 Redditor
f1000: 2 research highlight platforms

Readers on

mendeley: 723 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 37,253 followers.

@kannireissaaja @SiriKartaKaur Nukutuksessa tehtyjä kontrolloituja tutkimuksia on tehty kuten esim. tässä Parkinsonin tautiin liittyen. https://t.co/SGOErxe9dO

@farhatrauf @FeinsteinIMR 2.) 'Modest clinical effect' Phase II results (45 subjects; 50:50 - treated:sham) announced in June 2010, published 2011 (https://t.co/Y0mwomsLSI). It is not clear why this new result has taken so long to come out. Will do some…

I think this might be it http://t.co/D4RAD1nkDe

RT @basbloem: new trial #LancetNeurology showed fake brain surgery in #Parkinson pts has tremendous placebo effect, lasting 6 months. http://t.co/crifA54

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.